Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4557)
All Articles published online
|
Publishing Process of This Article
|
Mar 16, 2022 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Au M, Mitrev N, Leong RW, Kariyawasam V. Dual biologic therapy with ocrelizumab for multiple sclerosis and vedolizumab for Crohn’s disease: A case report and review of literature. World J Clin Cases 2022; 10(8): 2569-2576 [PMID: 35434082 DOI: 10.12998/wjcc.v10.i8.2569] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i8/2569.htm |
| Number | Citing Articles |
| 1 |
Tiffany Kim, Allen Brinker, David Croteau, Paul R Lee, Laura E Baldassari, Jessica Stevens, Alice Hughes, Juli Tomaino, Arushi deFonseka, Tara Altepeter, Cindy M Kortepeter. Immune-mediated colitis associated with ocrelizumab: A new safety risk. Multiple Sclerosis Journal 2023; 29(10): 1275 doi: 10.1177/13524585231195854
|
| 2 |
A. Quesada-Simó, A. Garrido-Marín, P. Nos, S. Gil-Perotín. Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with de novo intestinal bowel disease in multiple sclerosis: a review. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1186016
|
| 3 |
Bindu Challa, Ashwini Kumar Esnakula. Histologic manifestations of ocrelizumab‐associated intestinal and hepatic injury in patients with multiple sclerosis. Histopathology 2024; 84(5): 765 doi: 10.1111/his.15120
|
| 4 |
Vittorio Viti, Chiara Zanetta, Ruggero Capra, Andrea Municchi, Maria A. Rocca, Massimo Filippi. Ocrelizumab-associated enteritis in patients with multiple sclerosis: an emerging safety issue. Journal of Neurology 2024; 271(9): 6368 doi: 10.1007/s00415-024-12553-4
|
| 5 |
Cristina Bezzio, Cristina Della Corte, Marta Vernero, Imma Di Luna, Gianpiero Manes, Simone Saibeni. Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations. Therapeutic Advances in Gastroenterology 2022; 15 doi: 10.1177/17562848221115312
|
| 6 |
Sarah Tolaymat, Kanika Sharma, Yusuf Kagzi, Shitiz Sriwastava. Anti-CD20 monoclonal antibody (mAb) therapy and colitis: A case series and review. Multiple Sclerosis and Related Disorders 2023; 75: 104763 doi: 10.1016/j.msard.2023.104763
|